RE:NewsYes..Their results from their Phase 2 on Rett Syndrome and in Q3 results Phase 2 on ALS..more importantly their Pharma partnership with approved Ketarx and Partnership with their PharmaPatch for start of clinical trials. Also, partnership with Pharma to start their Q3 Phase 3 clinical trial for Parkinsons. Also, imminant announcement on SPIN-OUT of Sairiyo scheduled for Q2....Lots on the table here..only time. Buying on daily lows..have a nice position, only time will tell. Two many announcements coming, to propell the stock price. Im in..big..My strategy..go big/or go home...this company is in a good solid position. Very low share count..CEO been buying last 2 year slowing and holds Over 15mm shares..cash good currently over $4.5mm with NO DEBT. Once approved for KETRAX.. will generate huge revenues instantly..so all in all, looks like a very good play to me for at least a 5X bagger and more..Once in a while you come across these rare potential plays..My belief is thats the case here..JUST MY OPINION...You form your own...Can't find any negatives here...ONLY, if FDA approval is declined or is pushed BACK a long time..Anyhow thats the RISK for face...